1. Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis 
Stefanie Hennig, Karen McKay, Suzanna Vidmar, Katie O'Brien, Sonya Stacey, Joyce Cheney, Claire E. Wainwright 
Journal of Cystic Fibrosis 
Volume 13, Issue 4, Pages (July 2014)
DOI: /j.jcf
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Change in GFR (ml/min) from prior to aminoglycoside exposure (first) to study completion (last).
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

3. Fig. 2
Difference in GFR (glomerular filtration rate) for children exposed to inhaled tobramycin (TOBI®) by duration of the inhaled tobramycin course.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

4. Fig. 3
Audiogram of child 710 exhibiting a mild hearing loss in the right ear.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions